With the US capping inhaler prices at $35 ... “With Fasenra and Breztri, AstraZeneca is well-positioned to dominate the evolving COPD market. GlobalData projects that, if approved, Fasenra ...

AstraZeneca’s recent presentation at the ... for half of the company’s total revenue by 2030. Key drivers include Breztri Aerosphere (budesonide, formoterol fumarate, and glycopyrrolate ...

With the US introducing a $35 inhaler price cap, competition between biologics and inhaled ... and improved outcomes are likely to capture a significant share of the moderate-to-severe COPD market ...

Asthma can cause excess mucus buildup in the lungs, leading to chest congestion. It usually worsens when you have a respiratory infection or when your allergies are acting up. However, you can also ...

like Breztri or Trelegy Ellipta). This group also includes SMART drugs like Symbicort (budesonide and formoterol fumarate dihydrate). Long-acting bronchodilators should not be used for an acute asthma ...

As the vaccine module of the Covid Inquiry gets underway, The Telegraph’s Investigations team explores the link between the AstraZeneca jab and a potentially deadly reaction. We hear from the ...